The world of small-cap health care investing is one of huge booms and major busts. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, helps you find those companies with a strong foundation that are best positioned to capitalize on future success.
Here are today's top-performing health care Small-Cap Stars as of noon on the east coast:
Horizon Pharma Inc. (HZNP)
Horizon Pharma Inc. gained 14.17% to $9.67 in morning trading today. Volume reached 5,102,010 by noon. The stock's average daily volume is 2,249,493 shares. Horizon Pharma Inc. has a 52-week high of $18.30 and a 52-week low of $2.11, and its 50-day SMA and 200-day SMA are $14.01 and $11.09 respectively.
Horizon Pharma Inc is a specialty pharmaceutical company. It has developed and is commercializing DUEXIS, VIMOVO and RAYOS/LODOTRA, each of which targets unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Cardiovascular Systems Inc. (CSII)
Cardiovascular Systems Inc. gained 9.55% to $31.08 in morning trading today. Volume reached 317,220 by noon. The stock's average daily volume is 148,162 shares. Cardiovascular Systems Inc. has a 52-week high of $37.73 and a 52-week low of $18.83, and its 50-day SMA and 200-day SMA are $29.41 and $30.76 respectively.
Cardiovascular Systems Inc develops, manufactures and markets devices for the treatment of vascular diseases. Its product include Stealth 360° PAD System, the Diamondback 360° PAD System, and the Diamondback Predator 360° PAD System.
Galena Biopharma Inc. (GALE)
Galena Biopharma Inc. gained 6.14% to $3.11 in morning trading today. Volume reached 2,961,880 by noon. The stock's average daily volume is 2,266,671 shares. Galena Biopharma Inc. has a 52-week high of $7.77 and a 52-week low of $1.66, and its 50-day SMA and 200-day SMA are $2.85 and $3.35 respectively.
Galena Biopharma Inc, is a biopharmaceutical company focused on developing and commercializing, targeted treatments that address unmet medical needs to advance cancer care.
Therapeuticsmd (TXMD)
Therapeuticsmd gained 5.05% to $4.99 in morning trading today. Volume reached 1,377,370 by noon. The stock's average daily volume is 2,663,888 shares. Therapeuticsmd has a 52-week high of $9.01 and a 52-week low of $2.03, and its 50-day SMA and 200-day SMA are $4.58 and $5.08 respectively.
TherapeuticsMD Inc is a specialty pharmaceutical company. It develops and markets branded prescription, generic prescription, and over-the-counter (non-prescription) products exclusively for women.
Arrowhead Research Corp (ARWR)
Arrowhead Research Corp gained 3.71% to $11.98 in morning trading today. Volume reached 815,772 by noon. The stock's average daily volume is 2,255,671 shares. Arrowhead Research Corp has a 52-week high of $27.63 and a 52-week low of $3.75, and its 50-day SMA and 200-day SMA are $12.89 and $13.10 respectively.
Arrowhead Research Corp is a biopharmaceutical company developing targeted RNAi therapeutics.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
There's no crystal ball that will tell you what the outcome of this or that clinical trial is going to be. Even if there were, the one astonishingly wealthy person who owns it probably wouldn't share. But that doesn't mean that investing in the right small-cap health care companies can't pay dividends in the long term. While the future of a company's lead therapy may not be certain, most of its present fundamentals are. And while investing in the small-cap biotech market will always be hit-or-miss, investing in solidly built players should help boost that batting average.
Our Small-Cap Stars system uses a complex statistical regression to isolate those fundamental factors that previous success stories had in common and then identifies those small caps that are the most similar to that profile in the present.
For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most indicative of a small-cap company's potential for success.
All data provided by QuoteMedia and was accurate as of 12:00 pm ET.